用于快速、轻松地从血浆/血清样品中纯化循环游离 DNA
不含血浆/血清细胞的循环 DNA 纯化试剂盒
用于快速、轻松地从血浆/血清样品中纯化循环游离 DNA
Register today to receive an exclusive 15% off* on your first order.
概述
这些试剂盒提供了一种快速、可靠、方便的自旋转柱方法,可从血浆/血清样本中分离出优质、高纯度、无抑制剂的无细胞循环 DNA (cfc-DNA)。纯化的血浆/血清 cfc-DNA 与所有下游应用完全兼容,包括 PCR、qPCR、甲基化敏感聚合酶链式反应和 Southern 印迹分析、微阵列和 NGS。
背景
血浆/血清中的无细胞循环 DNA(cfc-DNA)有可能为某些癌症和疾病以及母体血液中的胎儿 DNA 提供生物标记。目前,利用 cfc-DNA 作为生物标志物,用于多种癌症和自身免疫性疾病的早期诊断、预后和治疗监测方面取得了重大进展。无细胞线粒体 DNA (cfmtDNA) 的临床意义也在研究之中。这种 cfc-DNA 通常是小于 1000 bp 的短片段。此外,无细胞胎儿 DNA 已被广泛用作产前诊断的无创方法,包括早期鉴定胎儿性别、对遗传性疾病高风险家庭进行基因研究、恒河猴因子筛查、非整倍体筛查和子痫前期鉴定
血浆/血清无细胞循环 DNA 纯化微型试剂盒
适用于处理 10 μL 至 200 μL 的初始血浆/血清量。该试剂盒可从新鲜或冷冻血浆/血清样本中分离出各种大小的 cfc-DNA,纯化后的 DNA 会被洗脱到 25 µL 至 50 µL 的灵活洗脱体积中。
血浆/血清无细胞循环 DNA 纯化迷你试剂盒
适用于处理 200 μL 至 500 μL 的初始血浆/血清量。该试剂盒可从新鲜或冷冻血浆/血清样本中分离出各种大小的 cfc-DNA,纯化后的 DNA 会被洗脱到 25 µL 至 50 µL 的灵活洗脱体积中。
血浆/血清无细胞循环 DNA 纯化 Midi 试剂盒
适用于处理 1 mL - 4 mL 初始血浆/血清量。第一个色谱柱将处理大量输入的体液,然后在迷你色谱柱上进行浓缩,最终洗脱 25 µL 至 50 µL 的体液
血浆/血清无细胞循环 DNA 纯化 Maxi 试剂盒
适用于处理 5 mL-10 mL 初始血浆/血清量。第一个色谱柱将处理大量输入的体液,然后在迷你色谱柱上进行浓缩,最终洗脱 25 µL 至 50 µL 的体液
细节
Supporting Data
Figure 1. Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Micro Kit was used to purify circulating DNA from 50 µL, 100 µL and 200 µL plasma prepared from blood collected on citrate as an anticoagulant, and compared to Competitor Q's kit.
Two microlitres of the purified DNA was then used as the template in qPCR reactions to assess the relative amount of the purified housekeeping 5S rRNA gene. The relative amount of the 5S rRNA gene increases linearly with increasing the sample input volume. Norgen's kit showed the most consistent and the highest recovery of the housekeeping 5S rRNA gene as compared to the other isolation method.
Figure 2. Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Micro Kit as used to purify circulating DNA from 50 µL, 100 µL and 200 µL plasma prepared from blood collected on citrate as an anticoagulant.
Two microlitres of the purified DNA was then used as the template in qPCR reactions to assess the linearity of the purified housekeeping 5S rRNA gene from the different plasma volumes. Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Micro Kit was able to recover 96% of the 5S rRNA gene from 100 µL plasma relative to the amount that is present in 50 µL plasma. Moreover, 97% of the 5S rRNA gene was recovered from 200 µL plasma relative to the amount that is present in 100 µL plasma.
Figure 3. DNA was isolated from 50 µL, 100 µL and 200 µL plasma using Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Micro Kit.
Increasing volumes of the elution (2, 4 and 8 μL) were used in a 20 μL qPCR reaction to observe any decrease in Ct value. An increase in Ct values with increasing amount of template would be a clear indication of PCR inhibitors present in the sample. An increase in elution volume used as a template in the qPCR did not affect the Ct value generated from qPCR and in fact the Ct values tend to decrease with increasing the PCR input volume indicating that DNA purified from plasma using Norgen's kit is free of the common inhibitors usually present in plasma.
Figure 4. Purification of DNA from different plasma volumes using Mini Kit.
Norgen's Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit was used to purify circulating DNA from 200 µL, 300 µL and 400 µL plasma prepared from blood collected on citrate as an anticoagulant in comparison to Competitor Q's kits. Two microlitres of the purified DNA was then used as the template in qPCR reactions to assess the relative amount of the purified housekeeping 5S rRNA gene. The relative amount of the 5S rRNA gene increases linearly with increasing the sample input volume. Norgen's kit showed the most consistent and the highest recovery of the housekeeping 5S rRNA gene as compared to the other isolation method.
Figure 5. Linearity of DNA purified from increasing plasma volumes using Mini Kit.
Norgen's Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit was used to purify circulating DNA from 200 µL, 300 µL and 400 µL plasma prepared from blood collected on citrate as an anticoagulant. Two microlitres of the purified DNA was then used as the template in qPCR reactions to assess the linearity of the purified housekeeping 5S rRNA gene from the different plasma volumes. Norgen's Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit was able to recover 98% of the 5S rRNA gene from 300 µL plasma relative to the amount that is present in 200 µL plasma. Moreover, 98% of the 5S rRNA gene was recovered from 400 µL plasma relative to the amount that is present in 300 µL plasma.
Figure 6. Detection of the human 5S gene using Mini Kit.
DNA was isolated from 200 µL, 300 µL and 400 µL plasma using Norgen's Plasma/Serum Cell-Free Circulating DNA Purification Mini Kit. Increasing volumes of the elution (2, 4 and 8 μL) were used in a 20 μL qPCR reaction to observe any decrease in Ct value. An increase in Ct values with increasing amount of template would be a clear indication of PCR inhibitors present in the sample. An increase in elution volume used as a template in the qPCR did not affect the Ct value generated from qPCR and in fact the Ct values tend to decrease with increasing the PCR input volume indicating that DNA purified from plasma using Norgen’s kit is free of the common inhibitors usually present in plasma.
Figure 7. Purification of cell-free circulating DNA from different plasma volumes.
Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Midi Kit was used to purify circulating DNA from 0.5 mL, 1 mL, 2 mL and 4 mL plasma prepared from blood collected on citrate as an anticoagulant in comparison to Competitor Q's kits. Two microlitres of the purified DNA was then used as the template in qPCR reactions to assess the relative amount of the purified housekeeping 5S rRNA gene. The relative amount of the 5S rRNA gene increases linearly with increasing the sample input volume. Norgen's Kit showed the most consistent and the highest recovery of the housekeeping 5S rRNA gene as compared to the other isolation method.
Figure 8. Linearity of DNA purified from increasing plasma volumes using Norgen’s Plasma/Serum cell-free circulating DNA Purification Midi Kit.
Norgen’s Plasma/Serum cell-free circulating DNA Purification Midi Kit was used to purify circulating DNA from 0.5 mL, 1 mL, 2 mL and 4 mL plasma prepared from blood collected on citrate as an anticoagulant. Two microlitres of the purified DNA was then used as the template in qPCR reactions to assess the linearity of the purified housekeeping 5S rRNA gene from the different plasma volumes. Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Midi Kit was able to recover 97% of the 5S rRNA gene from 1 mL plasma relative to the amount that is present in 0.5 mL plasma. Moreover, 95% of the 5S rRNA gene was recovered from 2 mL plasma relative to the amount that is present in 1 mL plasma. Additionally, 95% of the 5S rRNA gene was recovered from 4 mL plasma relative to the amount that is present in 2 mL plasma.
Figure 9. Determination of the amount of inhibition present in plasma cell-free circulating DNA samples when detecting the human 5S gene.
DNA was isolated from 0.5 mL, 1 mL, 2 mL and 4 mL plasma using Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Midi Kit. Increasing volumes of the elution (2, 4 and 8 µL) were used in a 20 µL qPCR reaction to observe any decrease in Ct value. An increase in Ct values with increasing amount of template would be a clear indication of PCR inhibitors present in the sample. An increase in elution volume used as a template in the qPCR did not affect the Ct value generated from qPCR, and in fact the Ct values tend to decrease with increasing the PCR input volume indicating that DNA purified from plasma using Norgen’s kit is free of the common inhibitors usually present in plasma.
Figure 10. Norgen's Plasma/Serum cell-free circulating DNA Purification Maxi Kit was used to purify circulating DNA from 5 mL, 8 mL and 10 mL plasma prepared from blood collected on citrate as an anticoagulant in comparison to Competitor Q's kits.
Two milliliters of the purified DNA was then used as the template in qPCR reactions to assess the relative amount of the purified housekeeping 5S rRNA gene. The relative amount of the 5S rRNA gene increases linearly with increasing the sample input volume. Norgen's kit showed the most consistent and the highest recovery of the housekeeping 5S rRNA gene as compared to the other isolation method.
Figure 11. Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Maxi Kit was used to purify circulating DNA from 5 mL, 8 mL and 10 mL plasma prepared from blood collected on citrate as an anticoagulant.
Two milliliters of the purified DNA was then used as the template in qPCR reactions to assess the linearity of the purified housekeeping 5S rRNA gene from the different plasma volumes. Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Maxi Kit was able to recover 94% of the 5S rRNA gene from 8 mL plasma relative to the amount that is present in 5 mL plasma. Moreover, 96% of the 5S rRNA gene was recovered from 10 mL plasma relative to the amount that is present in 10 mL plasma.
Figure 12. DNA was isolated from 5 mL, 8 mL and 10 mL plasma using Norgen’s Plasma/Serum Cell-Free Circulating DNA Purification Maxi Kit.
Increasing volumes of the elution (2, 4 and 8 µL) were used in a 20 µL qPCR reaction to observe any decrease in Ct value. An increase in Ct values with increasing amount of template would be a clear indication of PCR inhibitors present in the sample. An increase in elution volume used as a template in the qPCR did not affect the Ct value generated from qPCR and in fact the Ct values tend to decrease with increasing the PCR input volume indicating that DNA purified from plasma using Norgen’s kit is free of the common inhibitors usually present in plasma.
支持数据
图 1.Norgens 血浆/血清无细胞循环 DNA 纯化微型试剂盒用于从 50 µL、100 µL 和 200 µL 的血浆中纯化循环 DNA,这些血浆是用柠檬酸盐作为抗凝剂采集的。然后将 2 μL 纯化 DNA 用作 q 聚合酶链式反应的模板,以评估纯化的管家 5S rRNA 基因的相对含量。5S rRNA 基因的相对含量随样本输入量的增加而线性增加。与其他分离方法相比,Norgen 的试剂盒对管家 5S rRNA 基因的回收最稳定,回收率也最高。
图 2.Norgens 血浆/血清无细胞循环 DNA 纯化微型试剂盒用于从 50 µL、100 µL 和 200 µL 的血浆中纯化循环 DNA。然后将 2 μL 纯化 DNA 用作 q 聚合酶链式反应的模板,以评估不同血浆容量中纯化的管家 5S rRNA 基因的线性度。Norgens 血浆/血清无细胞循环 DNA 纯化微型试剂盒能够从 100 µL 血浆中回收 96% 的 5S rRNA 基因,而 50 µL 血浆中的含量仅为 96%。此外,与 100 µL 血浆中的含量相比,从 200 µL 血浆中回收了 97% 的 5S rRNA 基因。
图 3.使用 Norgens 血浆/血清无细胞循环 DNA 纯化微试剂盒从 50 µL、100 µL 和 200 µL 血浆中分离 DNA。在 20 升 q 聚合酶链式反应中使用的洗脱液体积(2、4 和 8 升)不断增加,以观察 Ct 值是否下降。随着模板量的增加,Ct 值也会增加,这清楚地表明样本中存在聚合酶链式反应抑制剂。增加 qPCR 中用作模板的洗脱体积并不会影响 qPCR 生成的 Ct 值,事实上,Ct 值往往会随着聚合酶链式反应输入体积的增加而降低,这表明使用 Norgen 试剂盒从血浆中纯化的 DNA 不含血浆中常见的抑制剂。
图 4.与竞争对手 Q 的试剂盒相比,Norgen 的血浆/血清无细胞循环 DNA 纯化迷你试剂盒用于从 200 µL、300 µL 和 400 µL 的血浆中纯化循环 DNA。然后将 2 μL 纯化 DNA 用作 q 聚合酶链式反应的模板,以评估纯化的管家 5S rRNA 基因的相对含量。5S rRNA 基因的相对含量随样本输入量的增加而线性增加。与其他分离方法相比,Norgen 的试剂盒方法对看家 5S rRNA 基因的回收最稳定,回收率也最高。
图 5.Norgen 血浆/血清无细胞循环 DNA 纯化迷你试剂盒用于从 200 µL、300 µL 和 400 µL 的血浆中纯化循环 DNA。然后将 2 μL 纯化 DNA 用作 q 聚合酶链式反应的模板,以评估不同血浆容量中纯化的管家 5S rRNA 基因的线性度。相对于 200 µL 血浆中的含量,Norgen 的血浆/血清无细胞循环 DNA 纯化迷你试剂盒能够从 300 µL 血浆中回收 98% 的 5S rRNA 基因。此外,与 300 µL 血浆中的含量相比,从 400 µL 血浆中回收了 98% 的 5S rRNA 基因。
图 6.使用 Norgen 血浆/血清无细胞循环 DNA 纯化迷你试剂盒从 200 µL、300 µL 和 400 µL 血浆中分离 DNA。在 20 升 q 聚合酶链式反应中使用的洗脱液体积(2、4 和 8 升)不断增加,以观察 Ct 值是否下降。随着模板量的增加,Ct 值也会增加,这清楚地表明样本中存在聚合酶链式反应抑制剂。qPCR 中用作模板的洗脱体积的增加并不影响 qPCR 生成的 Ct 值,事实上,Ct 值有随着聚合酶链式反应输入体积的增加而降低的趋势,这表明使用 Norgens 试剂盒从血浆中纯化的 DNA 不含血浆中常见的抑制剂。
图 7.从不同体积的血浆中纯化无细胞循环 DNA。与竞争对手 Q 的试剂盒相比,Norgens 血浆/血清无细胞循环 DNA 纯化 Midi 试剂盒用于从 0.5 mL、1 mL、2 mL 和 4 mL 血浆中纯化循环 DNA,这些血浆采用柠檬酸盐作为抗凝剂收集的血液制备而成。然后将 2 μL 纯化 DNA 用作 q 聚合酶链式反应的模板,以评估纯化的管家 5S rRNA 基因的相对含量。5S rRNA 基因的相对含量随样本输入量的增加而线性增加。与其他分离方法相比,Norgen 试剂盒对管家 5S rRNA 基因的回收最稳定,回收率也最高。
图 8.使用 Norgens 血浆/血清无细胞循环 DNA 纯化 Midi 试剂盒从增加的血浆体积中纯化 DNA 的线性度。Norgens 血浆/血清无细胞循环 DNA 纯化 Midi 试剂盒用于纯化 0.5 mL、1 mL、2 mL 和 4 mL 血浆中的循环 DNA,这些血浆采用柠檬酸盐作为抗凝剂收集的血液制备而成。然后将 2 μL 纯化 DNA 用作 q 聚合酶链式反应的模板,以评估不同血浆容量中纯化的管家 5S rRNA 基因的线性度。Norgens 血浆/血清无细胞循环 DNA 纯化 Midi 试剂盒能够从 1 mL 血浆中回收 97% 的 5S rRNA 基因,而 0.5 mL 血浆中的回收率仅为 97%。此外,相对于 1 mL 血浆中的含量,从 2 mL 血浆中可回收 95% 的 5S rRNA 基因。此外,与 2 mL 血浆中的含量相比,从 4 mL 血浆中回收了 95% 的 5S rRNA 基因。
图 9.在检测人类 5S 基因时,确定无血浆细胞循环 DNA 样本中的抑制量。使用 Norgens 血浆/血清无细胞循环 DNA 纯化 Midi 试剂盒从 0.5 mL、1 mL、2 mL 和 4 mL 血浆中分离 DNA。在 20 µL q 聚合酶链式反应中使用的洗脱液体积不断增加(2、4 和 8 µL),以观察 Ct 值是否下降。随着模板量的增加,Ct 值也会增加,这清楚地表明样本中存在聚合酶链式反应抑制剂。增加 qPCR 中用作模板的洗脱体积并不会影响 qPCR 生成的 Ct 值,事实上,Ct 值有随着聚合酶链式反应输入体积的增加而降低的趋势,这表明使用 Norgens 试剂盒从血浆中纯化的 DNA 不含通常存在于血浆中的常见抑制剂。
图 10.与竞争对手 Q 的试剂盒相比,Norgen 的血浆/血清无细胞循环 DNA 纯化 Maxi 试剂盒用于从 5 mL、8 mL 和 10 mL 的血浆中纯化循环 DNA,这些血浆是用柠檬酸盐作为抗凝剂采集的。然后将两毫升纯化 DNA 用作 q 聚合酶链式反应的模板,以评估纯化的管家 5S rRNA 基因的相对含量。5S rRNA 基因的相对含量随样本输入量的增加而线性增加。与其他分离方法相比,Norgen 的试剂盒对管家 5S rRNA 基因的回收最稳定,回收率也最高。
图 11.Norgens 血浆/血清无细胞循环 DNA 纯化 Maxi 试剂盒用于纯化 5 mL、8 mL 和 10 mL 血液中的循环 DNA。然后将两毫升纯化 DNA 用作 q 聚合酶链式反应的模板,以评估不同血浆容量中纯化的管家 5S rRNA 基因的线性度。Norgens 血浆/血清无细胞循环 DNA 纯化 Maxi 试剂盒能够从 8 mL 血浆中回收 94% 的 5S rRNA 基因,而 5 mL 血浆中的含量仅为 94%。此外,相对于 10 mL 血浆中的含量,从 10 mL 血浆中回收了 96% 的 5S rRNA 基因。
图 12.使用Norgens 血浆/血清无细胞循环 DNA 纯化 Maxi 试剂盒从 5 mL、8 mL 和 10 mL 血浆中分离 DNA。在 20 µL q 聚合酶链式反应中使用的洗脱液体积不断增加(2、4 和 8 µL),以观察 Ct 值是否下降。随着模板量的增加,Ct 值也会增加,这清楚地表明样本中存在聚合酶链式反应抑制剂。qPCR 中用作模板的洗脱体积的增加并不影响 qPCR 生成的 Ct 值,事实上,Ct 值有随着聚合酶链式反应输入体积的增加而降低的趋势,这表明使用 Norgens 试剂盒从血浆中纯化的 DNA 不含血浆中常见的抑制剂。
| 试剂盒规格 | |
| 最小等离子体/血清输入 | 10 μL |
| 最大血浆/血清输入量 | 200 μL |
| 纯化的 DNA 大小 | ≥ 50 bp |
| 洗脱体积 | 25-50 μL |
| 完成 10 次净化所需的时间 | 15-20 分钟 |
| 平均产量* | 视标本而定 |
*请查看产品手册第 7 页,了解血浆/血清平均产量和常用 DNA 定量方法。
储存条件和产品稳定性
所有溶液都应密封保存在室温下。该试剂盒自发货之日起 2 年内保持稳定。试剂盒中含有即用型蛋白酶 K,它溶解在专门配制的储存缓冲液中。缓冲蛋白酶 K 在室温下保存可在发货日期后 2 年内保持稳定。
Documentation
- in a timely manner that considers the person's accessibility needs due to disability; and
- at a cost that is no more than the regular cost charged to other persons